Filing Details

Accession Number:
0001188112-11-000567
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-03-14 16:18:13
Reporting Period:
2011-01-06
Filing Date:
2011-03-14
Accepted Time:
2011-03-14 16:18:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1063530 Power 3 Medical Products Inc PWRM Services-Commercial Physical & Biological Research (8731) 650565144
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1298869 R Helen Park
26022 Budde Road
The Woodlands TX 77380
Interim Ceo And Interim Cfo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Disposition 2011-01-06 500,000 $11,000.00 23,032,337 No 5 S Indirect See Footnote
Common Stock, $0.001 Par Value Disposition 2011-01-27 19,500 $390.00 23,012,837 No 5 S Indirect See Footnote
Common Stock, $0.001 Par Value Disposition 2011-01-31 134,500 $2,690.00 22,878,337 No 5 S Indirect See Footnote
Common Stock, $0.001 Par Value Disposition 2011-02-04 96,000 $1,920.00 22,782,337 No 5 S Indirect See Footnote
Common Stock, $0.001 Par Value Disposition 2011-02-16 216,500 $4,130.00 22,565,837 No 5 S Indirect See Footnote
Common Stock, $0.001 Par Value Disposition 2011-02-28 112,000 $2,128.00 22,453,837 No 5 S Indirect See Footnote
Common Stock, $0.001 Par Value Disposition 2011-03-01 12,100 $230.00 22,441,737 No 5 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 S Indirect See Footnote
No 5 S Indirect See Footnote
No 5 S Indirect See Footnote
No 5 S Indirect See Footnote
No 5 S Indirect See Footnote
No 5 S Indirect See Footnote
No 5 S Indirect See Footnote
Footnotes
  1. These shares were sold by the reporting person primarily so that the net proceeds could be used by the reporting person to pay certain debt obligations that Power3 Medical Products, Inc. owed to third parties.
  2. These shares were issued to Bronco Technology, Inc., a company of which the reporting person owns all of the issued and outstanding capital stock.